Connection

BENJAMIN SHNEIDER to Retrospective Studies

This is a "connection" page, showing publications BENJAMIN SHNEIDER has written about Retrospective Studies.
Connection Strength

0.522
  1. Characteristics of infections and their risk factors in children with biliary atresia. Clin Res Hepatol Gastroenterol. 2023 04; 47(4):102109.
    View in: PubMed
    Score: 0.060
  2. Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy. Hepatology. 2023 03 01; 77(3):862-873.
    View in: PubMed
    Score: 0.060
  3. Assessment of telemedicine versus in-person care in managing abdominal pain in children during the COVID-19 pandemic. J Telemed Telecare. 2024 Apr; 30(3):538-542.
    View in: PubMed
    Score: 0.058
  4. Operational Definitions for Chronic Liver Disease Manifestations and Recurring Clinical Events in Biliary Atresia. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):584-591.
    View in: PubMed
    Score: 0.053
  5. Factors Influencing Time-to-diagnosis of Biliary Atresia. J Pediatr Gastroenterol Nutr. 2018 Jun; 66(6):850-856.
    View in: PubMed
    Score: 0.043
  6. Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease). Liver Transpl. 2010 Jul; 16(7):856-63.
    View in: PubMed
    Score: 0.025
  7. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment. J Pediatr Gastroenterol Nutr. 2007 May; 44(5):596-602.
    View in: PubMed
    Score: 0.020
  8. Hepatitis C in children: a quaternary referral center perspective. J Pediatr Gastroenterol Nutr. 2006 Aug; 43(2):209-16.
    View in: PubMed
    Score: 0.019
  9. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006 Apr; 148(4):467-474.
    View in: PubMed
    Score: 0.019
  10. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience. Liver Transpl. 2005 Jul; 11(7):788-795.
    View in: PubMed
    Score: 0.018
  11. Abnormal concentrations of esterified carnitine in bile: a feature of pediatric acute liver failure with poor prognosis. Hepatology. 2005 Apr; 41(4):717-21.
    View in: PubMed
    Score: 0.017
  12. MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology. 2002 Mar; 222(3):687-91.
    View in: PubMed
    Score: 0.014
  13. Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency. Hepatology. 2021 08; 74(2):892-906.
    View in: PubMed
    Score: 0.013
  14. Non-adherence in pediatric liver transplant recipients--an assessment of risk factors and natural history. Pediatr Transplant. 2000 Aug; 4(3):200-6.
    View in: PubMed
    Score: 0.013
  15. Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates. JAMA Pediatr. 2018 11 01; 172(11):1070-1077.
    View in: PubMed
    Score: 0.011
  16. Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. Hepatology. 2017 05; 65(5):1645-1654.
    View in: PubMed
    Score: 0.010
  17. Clinical Variability After Partial External Biliary Diversion in Familial Intrahepatic Cholestasis 1 Deficiency. J Pediatr Gastroenterol Nutr. 2017 03; 64(3):425-430.
    View in: PubMed
    Score: 0.010
  18. Newborn Direct or Conjugated Bilirubin Measurements As a Potential Screen for Biliary Atresia. J Pediatr Gastroenterol Nutr. 2016 06; 62(6):799-803.
    View in: PubMed
    Score: 0.009
  19. Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl. 2014 Oct; 20(10):1168-77.
    View in: PubMed
    Score: 0.008
  20. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol. 2010 Jul; 53(1):170-8.
    View in: PubMed
    Score: 0.006
  21. The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring. Pediatr Transplant. 2010 Jun; 14(4):504-11.
    View in: PubMed
    Score: 0.006
  22. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients. Transplantation. 2009 May 15; 87(9):1318-24.
    View in: PubMed
    Score: 0.006
  23. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):239-45.
    View in: PubMed
    Score: 0.006
  24. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology. 2007 Nov; 46(5):1632-8.
    View in: PubMed
    Score: 0.005
  25. Adherence and medical outcomes in pediatric liver transplant recipients who transition to adult services. Pediatr Transplant. 2007 Sep; 11(6):608-14.
    View in: PubMed
    Score: 0.005
  26. Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis. Pediatr Transplant. 2004 Dec; 8(6):571-5.
    View in: PubMed
    Score: 0.004
  27. The role of magnetic resonance cholangiography in the management of children and young adults after liver transplantation. Pediatr Transplant. 2001 Dec; 5(6):410-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.